Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function
Authors:
- Anna-Karin ÅkermanAÅAnna-Karin Åkerman
- Åse Bjorvatn SævikÅSÅse Bjorvatn Sævik
- Per Medbøe ThorsbyPTPer Medbøe Thorsby
- Paal MethliePMPaal Methlie
- Marcus QuinklerMQMarcus Quinkler
- Anders Palmstrøm JørgensenAJAnders Palmstrøm Jørgensen
- Charlotte HöybyeCHCharlotte Höybye
- Aleksandra J. DebowskaADAleksandra J. Debowska
- Bjørn Gunnar NedrebøBNBjørn Gunnar Nedrebø
- Anne Lise DahleADAnne Lise Dahle
- Siri CarlsenSCSiri Carlsen
- Aneta TomkowiczATAneta Tomkowicz
Open Access
- 22 May 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (10) , 3602
Abstract
Purpose: Residual adrenocortical function, RAF, has recently been demonstrated in one-third of patients with autoimmune Addison’s disease (AAD). Here, we set out to explore any influence of RAF on the levels of plasma metanephrines and any changes following stimulation with cosyntropin. Methods: We included 50 patients with verified RAF and 20 patients without RAF who served as controls upon cosyntropin stimulation testing. The patients had abstained from glucocorticoid and fludrocortisone replacement > 18 and 24 h, respectively, prior to morning blood sampling. The samples were obtained before and 30 and 60 min after cosyntropin stimulation and analyzed for serum cortisol, plasma metanephrine (MN), and normetanephrine (NMN) by liquid-chromatography tandem-mass pectrometry (LC-MS/MS). Results: Among the 70 patients with AAD, MN was detectable in 33%, 25%, and 26% at baseline, 30 min, and 60 min after cosyntropin stimulation, respectively. Patients with RAF were more likely to have detectable MN at baseline (p = 0.035) and at the time of 60 min (p = 0.048) compared to patients without RAF. There was a positive correlation between detectable MN and the level of cortisol at all time points (p = 0.02, p = 0.04, p < 0.001). No difference was noted for NMN levels, which remained within the normal reference ranges. Conclusion: Even very small amounts of endogenous cortisol production affect MN levels in patients with AAD.Keywords
Funding Information
- Norges Forskningsråd (288022, NNF18OC0034130)
- Novo Nordisk Fonden (288022, NNF18OC0034130)
- Internal Medicine Association of Norway (288022, NNF18OC0034130)
- Regional Agreement on Medical Training and Clinical Research in Stockholm (288022, NNF18OC0034130)
- legate of Dr. Nils Henrichsen and his Wife Anna Henrichsen (288022, NNF18OC0034130)
This publication has 34 references indexed in Scilit:
- Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian RegistryThe Journal of Clinical Endocrinology & Metabolism, 2009
- Cross‐talk between Adrenal Medulla and Adrenal Cortex in StressAnnals of the New York Academy of Sciences, 2008
- Reduced epinephrine reserve in response to insulin-induced hypoglycemia in patients with pituitary adenomaEuropean Journal of Endocrinology, 2007
- Absence of Exercise-Induced Leptin Suppression Associated with Insufficient Epinephrine Reserve in Patients with Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase DeficiencyExperimental and Clinical Endocrinology & Diabetes, 2006
- Adrenomedullary Dysplasia and Hypofunction in Patients with Classic 21-Hydroxylase DeficiencyNew England Journal of Medicine, 2000
- The autoimmune basis of adrenocortical destruction in Addison's diseaseMolecular Medicine Today, 1996
- Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines.The Journal of Clinical Endocrinology & Metabolism, 1995
- Plasma catecholamines in patients with Addison's diseaseClinical Endocrinology, 1995
- Prolonged acth treatment increases trypsin-like and phenylethanolamine-N-methylsransferase (PNMT) activity in the adrenalsEuropean Journal of Pharmacology, 1984
- Adrenaline Synthesis: Control by the Pituitary Gland and Adrenal GlucocorticoidsScience, 1965